Nevertheless, our results suggest that dietary PUFAs attenuated hepatic NLRP3 inflammasome activation (Fig. 2), which in part explains the reduced hepatic steatosis in mice fed dietary PUFAs. Here, NLRP3 is linked to fatty liver disease.